Natera
NAS:NTRA
Biotechnology
—
SMALL cap
(—)
—
since start of 2022
—
About
BiotechnologyFounded 2003
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test; Horizon Carrier Screening; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis; Anora Products of Conception; and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
Headquarters
Executives
Name | Title | Gender |
Matthew Rabinowitz, PhD | Chairman, President & Chief Executive Officer | Male |
Jonathan Sheena | Director & Chief Technology Officer | Male |
Daniel Rabinowitz | Secretary & General Counsel | Male |
Mike Brophy, MBA | CFO, Director & Head-Investor Relations | Male |
Damon Silvestry | Vice President-Operations | Male |
Michael C. Little, PhD | Senior Vice President-Research & Development | Male |
Joshua Leichter | Vice President-Legal & Corporate Affairs | Male |
Cheng-Ho Lin, PhD | Chief Scientific Officer |
Mindful Investing Summary
Natera - Competitors and Related Companies
How Natera stacks up to its peers in theBiotechnology industry or with competing business segments.
Natera
NAS:NTRA
Biotechnology
—
SMALL cap
(—)
—
since start of 2022
—
Paratek Pharmaceuticals
NAS:PRTK
Biotechnology
—
SMALL cap
(—)
—
since start of 2022
—
Prothena
NAS:PRTA
Biotechnology
—
SMALL cap
(—)
—
since start of 2022
—
Pluristem Therapeutics
NAS:PSTI
Biotechnology
—
MICRO cap
(—)
—
since start of 2022
—
Vertex Pharmaceuticals
NAS:VRTX
Biotechnology
—
LARGE cap
(—)
—
since start of 2022
—